JG
VBIV

Joel Greenblatt’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Joel Greenblatt’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,267
Closed -$304K – 1156
2020
Q2 		$304K Buy
+3,267
New +$180K 0.01% 860

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Joel Greenblatt's VBIV Position: Q3 2020 in Review

Joel Greenblatt sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2020, closing a stake of 3,267 shares — an estimated $304K sold.

Joel Greenblatt first reported a position in VBIV in Q2 2020 and held it in 1 quarter. The position peaked at $304K in Q2 2020. 114 funds tracked by Wall St. Rank hold VBIV as of Q3 2020.

  • Joel Greenblatt reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2020 after selling out during the quarter.
  • Joel Greenblatt sold 3,267 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2020, an estimated $304K.
  • Joel Greenblatt first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 1 quarter.
  • Joel Greenblatt's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $304K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2020.

Based on Gotham Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.